Abstract Levamisole phosphate, chosen based on its 100 % efficacy demonstrated by a previous fecal egg count reduction test (FECRT), was used as the exclusive anthelmintic treatment in the Embrapa Southeast Livestock sheep flock from 2009 to 2014 in a target selected treatment scheme. In the present study, the effectiveness of this nematode control scheme was evaluated after 5 years by FECRT, larval development test (LDT), and a molecular test to assess the development of levamisole resistance in Haemonchus contortus. Animals were submitted to treatments with albendazole, levamisole, closantel, ivermectin, moxidectin, and monepantel. Eggs per gram of feces (EPG) counts and fecal cultures were performed, and anthelmintic efficacy was calculated by the RESO 4.0 program. The helminths of the flock (GIN Embrapa2014) were compared to susceptible (McMaster) and resistant (Embrapa2010) H. contortus isolates in the LDT to estimate the LC 50 and LC 90 of levamisole and in a molecular test to evaluate the 63-bp indel in the acr8 gene associated with levamisole resistance. In the FECRT, parasites were susceptible to monepantel (99.6 %) and closantel (98.3 %), but resistant to moxidectin (93.8 %), levamisole (70.4 %), ivermectin (48.1 %), and albendazole (0 %). In the coproculture on D14, and the control group presented 80 % H. contortus and 20 % Trichostrongylus sp., while in the monepantel group L 1 were observed as well as Oesophagostomum sp. L 3 . LDT and resistance factors provided good separation between susceptible and resistant parasites. The genotypic frequencies of the 63-bp insertion in the acr8 gene in H. contortus were 11.9, 6.7, and 0 % in GIN Embrapa2014, Embrapa2010, and McMaster isolates, respectively. After 5 years of exclusive use, the nematodes developed resistance to levamisole, detected by FECRT and by increase in LC 50 and LC 90 for levamisole in the LDT. The 63-bp indel was not confirmed as a molecular marker of levamisole resistance in our isolates. The target selected treatment scheme was effective to control helminths in the sheep flock for 5 years, when levamisole's inefficacy was perceived because of no change in the clinical situation of treated animals. Through this scheme, it was possible to promote reversion towards susceptibility or increase of efficacy for other chemical classes. Thus, this is a valid recommendation to control worms and to delay the development of resistance, preserving other anthelmintic classes for future use.
Introduction
Gastrointestinal nematode infections remain one of the most prevalent and important issues affecting small ruminants worldwide. The problem of parasite resistance to chemotherapeutic drugs has gradually grown from sporadic occurrence in the early 1960s to the current status where anthelmintic resistance threatens the sustainability of many intensive production systems. At present, anthelmintic resistance occurs in several genera and classes of helminths to all three groups of commercially available anthelmintics-the benzimidazoles, imidazothiazoles, and macrocyclic lactones (Várady et al. 2011) . Thus, the establishment of rational measures to prevent and control gastrointestinal nematodes in small ruminant flocks is a major challenge, especially in tropical regions and when the prevalent species is the blood-feeding Haemonchus contortus, whose parasitism results in hemorrhagic anemia (Amarante et al. 2004) .
Due to the large amount of data related to the development of resistance, there are some controversial recommendations regarding the use of drugs to control helminths. While some authors recommend rotation of anthelmintics within a year or after each treatment (Köse et al. 2007; Dobson et al. 2011) , others suggest rotating them slowly or annually (reviewed by Van Wyk 2001 and by Leathwick 2013) or using an anthelmintic until it is no longer effective (Le Jambre et al. 1977; Fleming et al. 2006) . Studies reveal that all three strategies are being adopted by farmers (Rojo-Vázquez and Hosking 2013), making it necessary to validate those recommendations in the field to assure they are efficient both to control gastrointestinal nematodes and to delay the development of anthelmintic resistance.
To address that condition, it is necessary to use methods for reliable detection of resistance. The main method remains the fecal egg count reduction test (FECRT), which can be performed with all anthelmintic groups in vivo. Nematode eggs are counted in feces at the time of treatment and at defined times afterward. Although the FECRT is considered the gold standard for detecting anthelmintic resistance, it is time consuming and expensive, often precluding its use (Coles et al. 2006) . As a consequence, there is a lack of information regarding the resistance status of flocks and management of the chemical groups in future years. On the other hand, in vitro tests are considered less expensive, faster, and in many cases more accurate and reproducible (Lacey et al. 1991; Hazelby et al. 1994; Várady et al. 1996) . Among them, the larval development test (LDT) is considered sensitive and practical, by enabling evaluation of resistance to more than one chemical group at the same time. It also does not depend on embryonated eggs (Kaplan et al. 2007 ). The results can be compared with reference isolates (susceptible and resistant), so it is possible to determine the LD 50 while eliminating inter-test interference (Craven et al. 1999 ). Many studies have demonstrated good correlation between FECRT results and the discriminatory LD 50 for the resistance obtained in vitro (Várady et al. 2006; Kaplan et al. 2007; Díez-Banos et al. 2008; Taylor et al. 2009 ).
Another approach is to use molecular tests to detect mutations present even at low frequencies in the population, thus assuring early detection and easy monitoring of resistance (Gasser et al. 2008) . These tests rely on the validation of polymorphisms in candidate genes as molecular markers of resistance. Benzimidazole was the first group for which the molecular mechanisms leading to resistance were elucidated (Coles 2005) . For levamisole, resistance was associated with alleles of the Mpi locus encoding mannose-phosphate isomerase enzyme in Oesophagostomum dentatum (Snábel et al. 2000) , with polymorphism in the nicotinic acetylcholine receptor gene (nAChR) in Ascaris suum (James et al. 2009) , and for H. contortus with the expression of a truncated transcript (Hco-acr-8b) (Fauvin et al. 2010 ) and with a 63-bp indel in one of the acetylcholine receptors sensitive to the levamisole (L-AChR1) gene (Hco-acr-8) (Barrère et al. 2014) .
In a previous study, high occurrence of multidrug resistance in 30 sheep flocks from São Paulo state was observed, and levamisole was the most efficient anthelmintic (Veríssimo et al. 2012) . Levamisole is an imidazothiazole widely used to control nematodes in ruminants (Fauvin et al. 2010; Klauck et al. 2014) . So, the implementation of strategies to control gastrointestinal nematodes with levamisole to preserve its efficacy for longer periods is important, through developing and validating tests to detect resistance to levamisole.
The objective of this study was to validate a target selected treatment scheme in a sheep flock as a feasible practice to control nematodes and to preserve anthelmintic efficacy, by determining how long levamisole in exclusive use remains effective. We also aimed to correlate in vitro and in vivo tests to assess levamisole resistance and to verify if the reported 63-bp indel in acr8 gene (Barrère et al. 2014 ) is associated with the phenotype of levamisole resistance in H. contortus of the studied sheep flock.
Materials and methods
All procedures were approved by the Embrapa Southeast Livestock Ethics and Animal Experimentation Committee (no. 06/2012).
Sheep flock and target selected helminth control scheme
The sheep flock of the Embrapa Southeast Livestock (Embrapa Pecuária Sudeste) has approximately 1400 animals of different breeds. They are kept on pasture during the whole year and supplemented during the dry season. The helminth control scheme for this flock is a target selected treatment, where the animals are selected for anthelmintic treatment (Van Wyk et al. 2006 ). This target selection was based on the number of eggs per gram of feces (EPG), which is monitored at least monthly, along with Famacha grade and packed cell volume (PCV). The animals are only treated when EPG >4000 and/or Famacha is 4 or 5 and/or PCV <20 % (Chagas et al. 2014) . Besides the target selected treatment, strategic deworming is performed in all ewes once in the periparturient period and in all lambs after weaning.
In a fecal egg count reduction test (FECRT) performed in 2008, the levamisole phosphate presented 100 % efficacy, while resistance was detected to benzimidazoles, macrocyclic lactones, and closantel (Veríssimo et al. 2012 (Oliveira et al. 2008) .
Fecal egg count reduction test
Forty-nine Santa Inês sheep with EPG higher than 200 and mean body weight of 56.7 kg were allocated in seven groups for FECRT based on average EPG (2685 on day 0). They were treated with one of the following compounds at the manufacturers' recommended doses: (1) oral albendazole plus cobalt sulfate, 5 mg/kg (Valbazen10 Cobalto®, Pfizer); (2) injectable levamisole phosphate, 6.2 mg/kg (Ripercol® L 150 F, Fort Dodge); (3) oral closantel, 10 mg/kg (Diantel®, Irfa); (4) injectable ivermectin, 0.2 mg/kg (1 % Ivomec®, Merial); (5) injectable moxidectin, 0.2 mg/kg (Cydectin®, Fort Dodge); (6) oral monepantel, 2.5 mg/kg (Zolvix®, Novartis); and (7) negative control (no treatment). Animals treated with albendazole and closantel were submitted to water and feed deprivation for 8 h before treatment.
During the experiment (May 2014), the animals were kept together in 1.7-ha pasture with Aruana grass (Panicum maximum cv. Aruana) and supplemented with 3 kg/animal/ day of corn silage and 200 g/animal/day of concentrated feed. Water and mineral mixture were supplied at will.
Individual EPG counts were performed on days 0 (D0) and 14 (D14) after treatment (Coles et al. 2006 ) by the modified McMaster technique (Gordon and Whitlock 1939) , using 2 g of feces in 28 mL of saturated saline solution and multiplying the total number of eggs by 50. Coprocultures were performed for each group before and after the treatments (Roberts and O'Sullivan 1950) .
LDT to detect levamisole resistance
For the LDT, we selected a susceptible isolate (McMaster; Gill et al. 1995) , and an isolate resistant to benzimidazole, macrocyclic lactone, and imidazothiazole (Embrapa2010; Chagas et al. 2013) , for comparison to the gastrointestinal nematodes from the flock (84 % H. contortus and 16 % Trichostrongylus sp.), called here GIN Embrapa2014. The GIN Embrapa2014 is derived from the GIN population from which the H. contortus Embrapa2010 strain was isolated. However, while Embrapa2010 was kept in sheep hosts with periodic passage without treatment from 2009 to 2014 (as well as in an original frozen culture), the GIN Embrapa2014 was kept in the field (animals and pastures) and exposed to the exclusive use of levamisole as anthelmintic treatment for 5 years.
Donor sheep infected with H. contortus McMaster and Embrapa2010 isolates were kept in separate pens, fed 400 g/ animal/day of shredded corn plus silage and water ad libitum. Eggs were obtained from fresh feces according to Coles et al. (1992) , as follows: about 5 g of feces, directly collected from the rectum, was mixed with tepid water (37°C) and filtered through sieves with mesh sizes of 1 mm and 106, 53, and 25 μm, the last to retain the eggs. Recovered eggs were added to a saturated NaCl solution and centrifuged at 3000 rpm for 5 min, and the floating eggs were collected using a 25-μm sieve and washed with distilled water.
The dilutions of tetramisole hydrochloride (SigmaAldrich) were from 0.0015 to 0.8 μg/mL for the McMaster isolate, from 0.003 to 1.56 μg/mL for Embrapa2010, and from 0.003 to 3.12 μg/mL for GIN Embrapa2014. Aliquots of the suspension containing approximately 100 eggs/30 μL were added to each well of a 24-well microplate with 80 μL of nutritive medium (Escherichia coli, yeast extract, amphotericin-B) according to Hubert and Kerboeuf (1992) . Then distilled water was added to complete the volume to 250 μL in each well. The plates were identified, sealed with PVC film, and placed in the incubator at 27±1°C and humidity >80 % to obtain L 1 larvae. After 24 h, 250 μL of each diluted drug was added in each well to obtain the final range of concentrations described above. The plates were incubated under the same conditions for 6 days, after which the L 1 , L 2 , and L 3 larvae in each well were counted under an inverted microscope. All concentrations and negative control (distilled water) were tested in six replicates (six wells) and in three independent experiments, in a total of approximately 1800 L 1 /treatment (Chagas et al. 2011) .
The development inhibition percentage for each concentration in each isolate was determined based on the arithmetic mean (x ) of the larval development, according to the following equation (Coles et al. 1992 ): Inhibition (%)=100 (x test /x total ), where, x test refers to the number of larvae that did not develop to L 3 , and x total corresponds to the number of L 1 +L 2 + L 3 .
DNA extraction and genotyping
H. contortus L 3 from the three isolates (McMaster, Embrapa2010, and Embrapa2014) were subjected to DNA extraction and genotyping of the 63-bp indel in the acr-8 gene, associated with levamisole resistance, by PCR according to Barrère et al. (2014) . Briefly, after coproculture, individual L 3 larvae were submitted to DNA extraction according to Silvestre and Humbert (2000) and Coles et al. (2006) , with modifications . After exsheathing with sodium hypochlorite, individual larvae were incubated in digestion buffer (10 mM Tris-HCl pH 7.6, 10 mM EDTA pH 8.0, 50 mM NaCl, 2 % SDS, 40 mM DTT, and 0.4 mg/ mL proteinase K) at 56°C overnight. Then DNA was extracted with phenol/chloroform/isoamyl alcohol (25:24:1), precipitated with 100 % isopropanol, washed with 70 % ethanol, and resuspended with 10 μL of water. Afterwards, the DNA was incubated at 37°C for 30 min and stored at −20°C.
PCR for genotyping of the 63-bp indel in H. contortus consisted of 1× buffer, 0.25 μM of each primer ForInsert (5′-ACCTTACCTATACACCCGTC-3′) and RevInsert (5′-CTTGCCGTTATTACACCCTCG-3′), 0.2 mM of each dNTP, 1.5 mM of MgCl 2 , 1 U of Taq DNA polymerase, and 2 μL of DNA (equivalent to 0.2 larvae), in a final volume of 20 μL. The thermocycling conditions were initial denaturing at 94°C for 2 min, 40 cycles of denaturing for 30 s at 94°C, annealing at 55°C, and extension at 72°C, followed by final extension at 72°C for 10 min. Genotypes were assigned by comparison to the 100-bp ladder after electrophoresis in 2.5 % agarose gel in 1× TBE buffer, staining with 5 μg/mL ethidium bromide and observation in a UV transilluminator. The genotype was assigned from the observed banding pattern: dd: homozygous for the 63-bp deletion (256 bp); ii: homozygous for the 63-bp insertion (319 bp); and id: heterozygous for the 63-bp indel (256 and 319 bp).
Statistical analysis
The anthelmintic efficacy was estimated using the RESO FECRT analytic software version 4.0. Anthelmintic resistance exists when efficacy is lower than 95 %, i.e., resistant status (R) <95 % and susceptible status (S) ≥95 % (Coles et al. 1992 (Coles et al. , 2006 .
The EPG data were submitted to the t test of the means using the SAS program to check for statistical difference between the average EPG counts on days 0 and 14, for each group. Results were analyzed as real EPG, checked for normal distribution by the UNIVARIATE procedure (SAS 2010) in the options Normal and Plot, after which the data were log transformed (ln(EPG+1)). The test results were considered significant when p≤0.05. The anthelmintic resistance degree was expressed as a resistance factor (RF) and was calculated as the values of LC 50 and LC 99 of the resistant isolates divided by the respective values of the susceptible isolates (Dolinská et al. 2013) , resulting in RF50 and RF99. The results of the LDT for the determination of the LC 50 and LC 90 were analyzed statistically by the Probit procedure of the SAS software.
Allelic and genotypic frequencies were compared by the chi-square test or Fisher's exact test (p<0.05), and genotypic frequencies in each isolate were tested for Hardy-Weinberg equilibrium (HWE) using Genepop (Raymond and Rousset 1995) .
Results

Levamisole resistance by FECRT
The statistical analysis of the FECRT results showed that the EPG of the control group and the groups treated with albendazole, levamisole, and ivermectin did not differ significantly between D0 and D14, for both real and transformed data. On the other hand, the log-transformed EPG data showed differences (p≤0.05) for closantel, moxidectin, and monepantel (Table 1) . These significance results were the same in the analysis of the real EPG, except for moxidectin, to which no significant difference was detected (p=0.1503 vs p=0.0046 in the ln(EPG+1)).
The GIN Embrapa2014 were susceptible to monepantel and closantel, with efficacy of 99.6 and 98.3 %, respectively, and resistant to moxidectin (93.8 %), levamisole (70.4 %), ivermectin (48.1 %), and albendazole (0 %). Those same results of susceptibility and resistance were obtained both when the EPG of the treated groups were compared with the EPG of the control group on day 14 (efficacy 1) and when the EPG of day 14 was compared to the EPG of day 0 in each group (efficacy 2) ( Table 1) .
In relation to the larval cultures, on D14 the animals in the control group showed 80 % H. contortus and 20 % Trichostrongylus sp., while in the monepantel group, Oesophagostomum larvae and L 1 of trichostrongylid nematodes were observed (Table 2) . Figure 1 presents the log-transformed values of the levamisole dilutions and their respective LCs, comparing the efficacy of the same drug for McMaster, Embrapa2010, and GIN Embrapa2014 isolates. This figure also demonstrates that the concentration response followed the same pattern for all three isolates.
Levamisole resistance by LDT
The resistance factor (RF) for levamisole was calculated. For the Embrapa2010 isolate, the RF50 was 1.57 and the RF99 was 1.60, while the respective values for GIN Embrapa2014 were 4.20 and 11.00.
Levamisole resistance by molecular testing
The allelic and genotypic frequencies of the 63-bp indel in the acr-8 gene (Fig. 2 ) in the three isolates of H. contortus (McMaster, Embrapa2010, and GIN Embrapa2014) are reported in Table 4 . An increase can be seen in the allelic and genotypic frequencies (i and ii, respectively) of the 63-bp insertion from 0.02 to 0.0 % in McMaster isolate, to 0.14 (p= 0.0029) and 6.7 % (p=0.1059) in Embrapa2010 isolate, and to 0.19 (p=0.0001) and 11.9 % (p=0.0153) in the field isolate GIN Embrapa2014. Departure from Hardy-Weinberg equilibrium (p<0.05) was observed only in the Embrapa2010 and GIN Embrapa2014 isolates (Table 4) . Table 3 , comparing to the results of FECRT and LDT, shows that reduction in levamisole efficacy in the two tests was accompanied by increase in genotypic frequencies of the 63-bp insertion (ii). However, the allelic (f(i)) and genotypic (ii) frequencies of insertion were not different (p=0.4461 and p = 0.5085, respectively) between Embrapa2010 and Embrapa2014 (Table 4) .
Discussion
The target selected treatment scheme, based on treatment of animals with EPG >4000, Famacha 4 or 5, and/or PCV <20 % and of periparturient ewes and lambs after weaning, with exclusive use of levamisole was effective to control helminths in the sheep flock for 5 years. Thus, this is a valid recommendation for farmers to control worms and delay the development of resistance, preserving the other anthelmintic classes for future use.
Two methods were used in RESO to calculate the efficacy of the anthelmintic treatments, and the results of anthelmintic resistance and susceptibility were the same in both. Thus, the choice of the method can be based on the available resources for experimentation, for example, number of animals available to form the control group. Another point is the ease of collecting feces for EPG in 2 days, day 0 to select the infected animals and day 14 to set the reduction of EPG in E1 or just one opportunity for collection (on day 14, comparing treated groups with control group) in E2. Our results are in agreement with those of Martin et al. (1989) , who indicated that the use of posttreatment counts alone provides an adequate indication of anthelmintic efficacy.
FECRT showed that levamisole efficacy dropped from 100 % (Veríssimo et al. 2012 ) to 70.4 % after 5 years of exclusive use. At the beginning of 2014, the inefficacy of levamisole was indirectly perceived through the observation *Day zero is the day on which the treatment was performed **The significance results were the same for the real EPG and the log-transformed EPG data (ln(EPG+1)), except to moxidectin, for which significant difference was detected in the log-transformed EPG (p=0.0046) and not in the real EPG (p=0.1503) The first 100 randomly selected L 3 were identified to the genus level. However, for levamisole, moxidectin and monepantel, it was not possible to recover the 100 L 3 , and all recovered larvae were counted b Plus 93 larvae of trichostrongylid nematodes in L 1 stage of no change in clinical situation of the treated animals and increased treatment frequency. So another FECRT was performed in the flock. In 2008, parasites of the Embrapa Southeast Livestock flock were susceptible to levamisole (100 %), but resistant to ivermectin (13 %), albendazole (0 %), moxidectin (33 %), and closantel (83 %) by FECRT, while monepantel was not evaluated (Veríssimo et al. 2012 ). After 5 years, parasites presented susceptibility to closantel (from 83 to 98.3 % efficacy) and remained resistant to moxidectin, ivermectin, and albendazole, but with improved values of efficacy to both moxidectin (from 33 to 93.8 % efficacy) and ivermectin (from 13 to 48.1 % efficacy). This suggests that reversion of resistance or reversion towards susceptibility occurred in the field due to the counter-selection promoted by the use of an alternative anthelmintic (Leathwick et al. 2001; Leathwick 2013) or by the dilution of resistant worms with susceptible genotypes (Jackson and Coop 2000) . In the literature, results regarding reversion are variable, depending on the levels of resistance genes in the population, and usually there is faster reestablishment of resistance (reviewed by Jackson and Coop 2000) . A significant improvement in the effectiveness of anthelmintic groups in a shorter period then observed by us was also observed in farms where the resistance was already well advanced. The size of the worm population in refugia was one of the points considered important for that reversion (Leathwick et al. 2015) . We believe that the parasite population that was not exposed to the anthelmintic groups for so many years in the present study was also crucial. On the other hand, resistance to albendazole was unchanged (0 % in 2008 and 2014) in the period of no use, confirming that when resistance is fully established and there are no genes for susceptibility in the parasite population, resistance seems to be permanent (Leathwick et al. 2001; Coles 2005) . The coproculture after 14 days showed that was not possible to recover 100 L 3 for genus identification in the moxidectin and monepantel groups, i.e., just 29 larvae developed in the moxidectin treatment group and six Oesophagostomum sp. larvae in the monepantel group. The recovery of Oesophagostomum sp. larvae in monepantel treatment, even in low number, confirms that this drug has no therapeutic indication to control inhibited larvae of Oesophagostomum venulosum, as well as adults and inhibited larvae of Oesophagostomum columbianum in small ruminants. Following euthanasia and worm counting, O. venulosum was only reduced by 88 % ), by 94 % , and by 92.7 % (adults) and 96.8 % (L 4 larvae) (Hosking et al. 2010) with monepantel. In a recent experiment in Brazil (Ciuffa et al. 2013) , 48 Oesophagostomum sp. larvae (the only genus observed) were recovered from fecal cultures after treatment with monepantel. The authors suggested that this active ingredient should be combined with other broad-spectrum drugs to treat flocks with high prevalence of Oesophagostomum sp. In the southeast of Brazil, where the present study was performed, O. columbianum is common, and the nodules are easily seen at necropsy at Embrapa Southeast Livestock. On the other hand, O. venulosum is rare and can be found just in the south of the country (Amarante 2009 ). This can be confirmed through the study in the south of Brazil performed by Bustamante et al. (2009) in sheep. For the genus Oesophagostomum, just O. venulosum was found (efficacy of 61.9 %) by worm count at necropsy after monepantel treatment. In this study, the resistance status to levamisole was confirmed through the FECRT and LDT. In the LDT, the LC 50 and LC 90 for levamisole increased from the McMaster to the GIN Embrapa2014 isolates. The doses to obtain lethal concentrations in the susceptible isolate were substantially lower than the LC values against the resistant parasites. As can be seen from the confidence limits in Table 3 , good separation between susceptible and resistant isolates was clear. This separation was particularly pronounced to levamisole in GIN Embrapa2014, as also indicated by the high RF values, mainly the RF99. Dolinská et al. (2013) stated that RF values higher than 3 demonstrate that the test was able to distinguish between susceptible and resistant isolates. Our results agree with theirs, according to which the RF for the LC 99 values were generally higher than those obtained by comparing LC 50 values. So, these results validate the LDT results and demonstrate a correlation between increased resistance detected in the field with increase of LCs obtained in vitro.
Regarding the DNA assay for levamisole resistance, departure from Hardy-Weinberg equilibrium was observed only in isolates subjected to treatments with anthelmintics (Embrapa2010 and Embrapa2014), suggesting that the 63-bp indel in acr-8 gene is undergoing selection. However, despite the increase in genotypic frequencies of the 63-bp insertion (ii), no significant differences were observed between Embrapa2010 and Embrapa2014 isolates. So, the 63-bp indel in acr-8 gene was not confirmed as a molecular marker of resistance in H. contortus in our isolates. As reported before (Barrère et al. 2014; Sarai et al. 2014) , besides acr-8, there are other genes involved in levamisole resistance, like unc-74, unc-63, unc-50, unc-38, unc-29 , and ric-3.1 and 3.2, and they should be further investigated. Barrère et al. (2014) reported that the presence of the 63-bp indel (which means the presence of a 319-bp band) was more frequently observed in susceptible isolates. However, for the susceptible McMaster isolate studied here, we observed the presence of the 256-bp band at a higher frequency. This finding was also presented in electrophoresis images from Barrère et al. (2014) , in which the exclusive presence of the 256-bp band was observed in the susceptible isolates ZAIRE-5, CRA-1, and CRA-2. Thus, the absence of the 63-bp insertion (or the exclusive presence of a 256-bp band) in acr-8 gene is not always associated with levamisole resistance in H. contortus.
There are different opinions related to the drug-use strategy to maximize the benefit of any fitness cost associated with resistance. According to Kaplan (2005) , the common practice of rotating drugs in each treatment does not slow the development of resistance and actually appears to increase the rate at which resistance develops, by selecting for resistance to more than one drug simultaneously. In contrast, some recommend that an anthelmintic should be used until it is no longer effective, after which drugs should be switched. In many areas, and heterozygous for the 63-bp indel-id (256 and 319 bp) in 8 and 22. Column 1: 100-bp ladder (from 100 to 1517 bp; with strong bands at 500 and 1000 bp); column 23: no template control or blank (NTC); columns 4, 9, and 23: no amplification; and column 11: genotype not assigned due to unexpected banding pattern there is really nothing to rotate to, so this approach is reasonable (Kaplan 2005; Anderson and Rings 2008) . Based on these ideas and our results, we can say that in the sheep flock from Embrapa Southeast Livestock, the exclusive and rational use of levamisole until it became inefficient was adequate to control gastrointestinal nematodes, delaying the establishment of resistance to this drug for 5 years and counter-selecting against resistance to closantel. Therefore, in July 2014, levamisole was replaced by exclusive use of closantel in this sheep flock, taking care to observe more frequently the anthelmintic efficacy of this drug due to its history of previous resistance. Monepantel will be reserved for future use, when decreased closantel efficacy becomes detectable by monitoring resistance. This kind of study provides important knowledge and tools to monitor the emergence of resistant parasites over time (Gilleard 2013 ) and provides practical recommendations to control gastrointestinal nematodes and to delay and detect the establishment of anthelmintic resistance.
